Alberto Penati received a High Technical School degree in mechanical engineering at the Feltrinelli Industry Institute in Milan, in 1990. From 1991 up to 1995 he worked at the FOSTER WHEELER Italy, Machine Dept., HVAC section, as a HVAC and utilities engineer for pharmaceutical and industrial plants. After a brief experience of one year (1995) at Woods (Italy), he was employed at Steril S.p.A up to 1998, as HVAC Engineer for pharmaceutical and biotech plants. After an experience in Eleca S.p.A. from 1998 up to 2000 as Project Engineer of mechanical plants, erection and construction, from 2000-2004 he worked at Jacobs Italy as HVAC and utilities Specialist for pharmaceutical, chemical, biotech and other appliances plants. From 2004 up to 2010 Alberto worked at CSV Life Science, for Project Management and construction activities in the Pharma sector. He is currently at Patheon, Italy (now part of Thermo Fisher Scientific) as EU Engineering sr Director.
Luigi holds an Electromechanichal Enginneer’s degree from ISTIM Milano. He is currently Aseptic Specialist & Strategic Marketing advisor at IMA LIFE Italy. He joined the IMA group in 1989 as Area Sales Manager Italy & Russia since 2010. Before joining IMA, he was first employed in an engineering company working in ISPRA Nuclear power plant. He then joined Alpina an engineered company as junior proposal manager and after same time he was appointed as Responsible of Proposal.
Jia Min, Boo is from Singapore and holds a Bachelor degree in Material Science Engineering from Nanyang Technological University in Singapore.
She joined West Pharmaceuticals Singapore since July 2013 as a technical account specialist. In her role, she provides technical support to pharma companies in the AP region, providing product recommendations, technical trainings and advices to ensure smooth and easy uptake of West’s wide product portfolio as required for customer’s drug product application.
Dr. Christina Juli studied pharmacy at the University of Wuerzburg, Germany. After her PhD thesis in the fields of pharmaceutical chemistry, in 2012, she joined the ratiopharm GmbH in Ulm, Germany. She started her professional career as Senior Manager in the department of EU Regulatory Affairs Generic Maintenance. Since 2018, she is working in the Tech RA department at Boehringer Ingelheim Pharma GmbH & Co. KG in Biberach, Germany. In her role as Head of Tech RA Germany III, she focuses on the CMC development for biologics and is responsible for the definition, compilation and review of the CMC documentation for clinical trial and new drug applications as well as for post approval submissions worldwide. Beyond that, as regulatory intelligence responsible for her business unit, she monitors the regulatory legislation, regulations, guidelines and position papers from pharmaceutical and biological industry worldwide. She is an active participant in the BioPhorum Operations Group (Post Approval Strategy working group).
Degree in Physics at Padua University in 1989, master in Nuclear Engineering in the 1990. As researcher at the National Research Council (C.N.R.) he developed several optoelectronic and nuclear scientific instruments for Magnetically Controlled Fusion Research setting up international collaboration with UWA Madison (USA) and Garchin IPP (De). After 10 years of activity in research he moved to the industrial sector developing optical and vision controls for industrial application as CEO of a small-medium company. This experience drove him into the pharmaceutical field, where he started to develop several control applications with vision and spectroscopy tools. After several years he joined a leading company in this sector as R&D Manager and he developed innovative inspection technology for the inspection machines.
Since 2008 he has been with Stevanato Group as Pharma Inspection Product Development Manager to develop new automation and inspection products dedicated to the pharmaceutical customers of the group.
Born 1984 in Germany, technical apprenticeship at Seidenader Maschinenbau GmbH (2001 - 2004). Visited University of Supplied Science in Munich from 2005. Graduated in 2009 as Dipl.-Ing. (Business and Engineering). Spending one semester in Seidenader's subsidiary "SV Research - Harrisburg/USA" and at the University of Plymouth / England.
Mr. Scherer then took on the role of Area Sales Manager at Seidenader Maschinenbau GmbH in Markt Schwaben,
Business Unit Inspection Machines from 2009 to 2015.
Since then, Mr. Scherer has led the sales & marketing team at Körber Pharma Inspection as the Executive Vice President - Sales
Since 2021 Member of the Board of Körber Japan.
Sok Tiang is an industrial pharmacist with extensive experience in the life cycle mgmt. of injectables from its packaging requirements to the manufacturing in the final finishing for market in a regulated environment. Currently the Vice President - Scientific Affairs & Technical Services for Asia Pacific, she joined West as the Regional Technical Services Manager after extensive experience in aseptic manufacturing in a multinational pharmaceutical company. Over her tenure in West, she has taken on differing roles of increasing responsibilities, from Business Development to Marketing and R&D.
With her training and experience, she provides technical solutions to address the customers in their pharmaceutical containment and delivery system challenges. In addition, she also offers insights in industry trends and regulatory requirements to support their needs.
Sok Tiang holds a Bachelor of Science in Pharmacy with Honors and MBA from the National University of Singapore.
Dr. Edward Yongxiang Wang has over twenty-five years of experience in pharmaceutical engineering and GMP manufacturing operations and specializes in biologics fill and finish production management. He is the Chief Technology Officer for China Operations of Sirnaomics Inc., a leading global RNAi therapeutics innovator. Dr. Wang’s expertise prior to this has been consulting services focusing in the areas of cGMP compliance on facility design, construction engineering, validation and technical operations.
Dr. Wang previously served as the Vice-President, Technical Operation at WuXiAppTec Biopharmaceuticals Co. Ltd., China responsible for the start-up of its site GMP production and quality system establishment. Prior to that, he was a director responsible for process development and engineering at AERAS Global TB Vaccine Foundation.
Dr. Wang received his Bachelor’s degree in Biophysics from the University of Science & Technology of China and a Doctorate degree in Biotechnology from Helsinki University of Technology, Finland. Dr. Wang has published over 50 peer-reviewed papers and has three patented biotechnology product. He has served on review committees for various biotech journals.